7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapy
This disclosure relates, at least in part, to a method of treatment. In one embodiment, the method of treatment comprises administering to a subject in need of such treatment a first therapeutic agent including compound (1): or a pharmaceutically acceptable salt thereof in combination with a second therapeutic agent, wherein the first therapeutic agent and the second therapeutic agent are administered either simultaneously or sequentially.
1. A method of treatment comprising administering to a subject having ovarian cancer in need of such treatment a pharmaceutically acceptable amount of compound (1):
or a pharmaceutically acceptable salt thereof, wherein the pharmaceutically acceptable amount of compound (1) is administered as a salvage therapy.
2. A method of treatment, comprising administering to a subject in need of such treatment a therapeutic agent comprising compound (1):
or a pharmaceutically acceptable salt thereof, wherein the treatment is for a genitourinary cancer and wherein the genitourinary cancer is ovarian cancer.